GlassScriptPhysician profile
Helen Kwong
NPI 1831339183
$7,345.45
in general payments reported to CMS, 2019-2025
38 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $1,305 · 2021: $1,508 · 2022: $1,612 · 2023: $892 · 2024: $479 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,398.68 | 2019-2025 | |
| Novo Nordisk INC | $1,378.78 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $672.05 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $598.98 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $297.75 | 2019-2022 | |
| Abbott Laboratories | $273.86 | 2021-2024 | Freestyle Libre 3 |
| Pfizer INC. | $257.28 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.80 | 2019-2022 | |
| Amgen INC. | $224.21 | 2019-2022 | |
| Allergan, INC. | $194.08 | 2019-2021 | |
| Amarin Pharma, INC. | $174.12 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.51 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $139.71 | 2019-2023 | Pneumovax 23, Vaxneuvance, Proquad |
| Sanofi-Aventis U.S. LLC | $131.90 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.11 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Kwong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.